Analyst Stance On Two Stocks: Qualys, Inc. (QLYS), Insmed Incorporated (INSM)

The recently concluded session had traders exchanging Qualys, Inc. (NASDAQ:QLYS) high level. Roughly 0.29 million shares changed hands compared to the three-month volume average 0.26 million shares. The first trade took place at $74.2 and the stock went up 3.61% to attain the closing price of $77.5.

Qualys, Inc. (QLYS) Analyst Opinion

Qualys, Inc. has a consensus hold rating from 16 Wall Street analysts, and the number of shares currently sold short amount to at least 4.61% of shares outstanding. The stock spiked 24% last month and is up 30.58 this year. Wall Street is only getting more bullish on the stock, with 5 of analysts who cover QLYS having a buy-equivalent rating. Analysts have placed a $69.15 price target on Qualys, Inc., suggesting a -10.77% decline from recent close. It’s currently trading about 0.52% above its 52-week high.

Qualys, Inc. Earnings Surprise

Qualys, Inc. (QLYS) surprised the stock market in its last reported earnings when it earned $0.32 a piece versus the consensus-estimated $0.28. Its revenue totaled $61.97 million up 4.17% from the previous quarter.

Qualys, Inc. (NASDAQ:QLYS) Intraday View

This stock (QLYS) is ahead of its 52-week low with 129.63%. Its last month’s stock price volatility remained 3.46% which for the week stands at 3.77%. The share price has moved forward from its 20 days moving average, trading at a distance of 14.06% and stays 20.05% away from its 50 days moving average. Over the last five days, shares have managed 3.06% gains and now is up 47.55% since hitting its 200-day moving average of $57.38. Qualys, Inc. (QLYS) has made its way to a 12-month gain of 122.38%.

Turning to Insmed Incorporated (NASDAQ:INSM), its shares were trading at $24.29 a gain of $0.81, on the trading floor. The stock, after opening at $23.28, touched a high of $24.55 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.9. Insmed Incorporated has 3 buy ratings, 2 holds and 0 sells even after the stock tumbled -28.43% from its high of $33.94 to a $1.76 billion market value through last close.

Insmed Incorporated (INSM) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 1.89 to 1.89 during a month. Analysts set a 12-month price target of $40 a share. The target implies a 64.68% spike from where the shares are currently trading. Also, the current price highlights a discount of 122.31% to analysts’ high consensus price target.

Insmed Incorporated (NASDAQ:INSM) Intraday Trading

The counter witnessed a trading volume of 0.94 million shares versus an average volume of 0.92 million shares during last trading session. Its last month’s stock price volatility remained 7.21% which for the week approaches 6.66%. The lowest price the stock reached in the last trading day was $22.84 and compares with the $11.49 52-week low. The stock recovered 111.4% since its low point and has performed -22.1% year-to-date.

Previous articleAnalysts Shared Their Read on 2 Stocks: Obsidian Energy Ltd. (OBE), Axovant Sciences Ltd. (AXON)
Next articleWall Street Stock Recommendations: Argos Therapeutics, Inc. (ARGS), Halozyme Therapeutics, Inc. (HALO)